arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

FRACTYL HEALTH, INC.

GUTS

$0.70 ▲ +0.01 (+1.67%) at close

14 Visible periods

22 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, FRACTYL HEALTH, INC. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $110.9M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -76.9% ↗

FCF / Share $-0.14

Trailing P/E 11.7x

Price / Book 5.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$14.00K

↓ -61.1% —

Net Income Profit after all expenses

$9.22M

↑ +121.1% —

FCF / Share Free cash flow per share

$-0.14

↑ +72.9% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -808.7% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -22.52x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.64x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	-61.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-864%)	-40.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-603%)	560.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6900%)	—	—	—	—	—
EPS Growth YoY (%)	N/M	86.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-47.9% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-58.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-188.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	95.3% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	95.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	97.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	97.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-75.1% Weak ↑ Weak Improving Year-over-year change in net income	-614.5% Weak ↓ Weak Declining Year-over-year change in net income	-614.5% Weak ↓ Weak Declining Year-over-year change in net income	-614.5% Weak ↓ Weak Declining Year-over-year change in net income	-30.2% Weak ↓ Weak Declining Year-over-year change in net income	72.2% Excellent → Excellent Stable Year-over-year change in net income	72.2% Excellent Excellent Year-over-year change in net income	72.2% Excellent Excellent Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	72.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	7.6% Fair ↑ Fair Improving Year-over-year change in free cash flow	-9.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	-21.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	92.9% Excellent → Excellent Stable Year-over-year change in free cash flow	93.0% Excellent Excellent Year-over-year change in free cash flow	90.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
FCF / Net Income (x)	-2.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	5.49x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	5.72x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	3.84x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-76.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-194.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	564.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	113.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-306.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-70.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	3.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	3.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-20.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-13.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-17.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	43.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+187%)	—	—	130.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+769%)	—	-87.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-686%)	-6.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-4.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-3.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	5.9% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	3.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	4.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-73%)	4.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-70%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Interest Coverage (x)	-19.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.95x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-25.10x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-22.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-32.15x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-36.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-34.69x Weak Weak Operating income divided by interest expense Optimal: > 5x	-21.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-63.17M	$-81.54M	$-77.66M	$-22.29M	$-42.11M	$-67.46M	—	—	$-121.44M	$-33.21M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.02	$0.03	$0.00	—
Basic EPS, GAAP (USD)	$0.06	$-0.07	$-0.71	$-0.57	$-0.49	$-0.53	$-0.48	$-0.36	$-0.17	$-11.18	$-9.61	$-16.62	$-7.87	—
Free Cash Flow per Share (USD)	$-0.14	—	$-0.35	$-0.43	$-0.52	—	$-0.38	$-0.40	$-0.43	—	$-5.34	$-5.64	$-4.66	—
Book Value per Share (USD)	$0.13	$0.06	$-0.02	$-0.36	$0.13	$0.58	$1.05	$1.48	$1.76	$-154.36	$-146.98	$-140.84	$-128.15	—
Tangible Book Value per Share (USD)	$0.13	$0.06	$-0.02	$-0.36	$0.13	$0.58	$1.05	$1.48	$1.76	$-154.36	$-146.98	$-140.84	$-128.15	—
Basic Weighted Avg Shares (shares)	158.49M	—	64.65M	49.04M	48.87M	—	47.97M	47.90M	29.74M	—	2.09M	2.08M	2.06M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$50.51M	$69.25M	$61.02M	$4.86M	$28.24M	$51.99M	—	—	$111.20M	$24.46M	—	—	—	—
Total Equity (USD)	$21.38M	$9.46M	$-3.18M	$-18.21M	$6.38M	$28.42M	$50.32M	$70.75M	$84.18M	$-325.06M	$-307.18M	$-292.52M	$-263.39M	$-252.32M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	$14.00K	$43.00K	$33.00K	—	$36.00K	$72.00K	$5.00K	—
Depreciation Expense (USD)	$281.00K	$279.00K	$290.00K	$270.00K	$290.00K	$223.00K	$209.00K	$192.00K	$53.00K	$38.00K	$84.00K	$84.00K	$80.00K	—
Net Income, GAAP (USD)	$9.22M	$-43.73M	$-23.73M	$-23.73M	$-23.73M	$-24.97M	$-3.32M	$-3.32M	$-3.32M	$-19.18M	$-11.93M	$-11.93M	$-11.93M	—
Operating Cash Flow (USD)	$-22.48M	$-21.34M	$-22.71M	$-21.20M	$-25.08M	$-17.03M	$-18.04M	$-18.74M	$-11.71M	$-10.60M	$-11.02M	$-11.66M	$-9.55M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 14 quarters

FRACTYL HEALTH, INC.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare GUTS with peers